Sliming boost for kids: Why more and more young people use Wegovy!

Sliming boost for kids: Why more and more young people use Wegovy!

In the USA, the number of weight loss injections that are prescribed for children and adolescents is constantly increasing. According to a report by Krone , more and more young people use Wegovy, a medication that has been approved for people from twelve years since 2022. The numbers are alarming: In 2022 there was an increase in new prescriptions by 50 % to 14.8 per 100,000 young people, and in the first quarter of 2023 they rose to 17.3 new prescriptions per 100,000.

Particularly worrying is the fact that around 23,000 out of 100,000 young people in the United States are considered pathologically overweight, which corresponds to almost every fourth adolescents. Cate Varney, director of obesity medicine at the University of Virginia, emphasizes that additional aids are required if lifestyle changes are not sufficient. Nevertheless, some doctors hesitate to prescribe Wegovy, while Minister of Health Robert Kennedy Jr. criticizes the large-scale prescription as "over-medication".

long -term effects and current challenges

A main concern is the lack of long -term data on the effects of Wegovy on the metabolism and growth development. The manufacturer Novo Nordisk emphasizes that the active ingredient Semaglutid in clinical studies had no influence on growth or puberty development. Nevertheless, there is often no support for the treatment of obesity with the health insurance companies, which also complicated the situation.

The use of medicines for obesity is not just a phenomenon in the USA. In Germany, too, obesity represents one of the greatest health challenges, such as "https://www.medizinicum.de/ therapist-mit-semaglut-ozempic- or-tirepatid-munjaro-Mat-mit- adipositas-update-2025/"> Medical. Here over 50 % of adults are overweight and about 23 % obese, while about 15 % of overweight and around 6 % are obese in children and adolescents.

consequences of obesity

The health risks of obesity are serious. The chronic state is considered a risk factor for numerous secondary diseases, including type 2 diabetes, high blood pressure and various types of tumor. The quality of life suffers questionable because many affected people have difficulties with mobility and social participation.

modern drugs such as Semaglutid and the upcoming Tirzatide promise support in weight reduction, but do not replace the need for lifestyle changes. The mechanism of action of Semaglutid, which regulates insulin and glucagon, shows that it can play a crucial role in weight management.

statistics on obesity in children

Additional statistics from the Kiggs study, such as "https://www.rki.de/de/themen/nichtusekläben-kinäusen/studien-und-surveillance/studien/studositas-monitoring/Adipositas/html_themenblatt_Dipositas.html"> rki show that 15.4 % of children and adolescents are overweight in Germany, while 5.9 % suffer from obesity. These figures are largely unchanged compared to the basic survey from 2003 to 2006, and there are regional differences in prevalence.

The overweight and obesity prolongs show a worrying trend. Obesity can cause health impairments in childhood and often leads to psychosocial stress that affects self -esteem. Without suitable measures, many risk suffering from these problems even in adulthood.